Table 4.
Reference | Sample source | Tissue type | Sample number | Success rate of transplantation | Evaluation |
---|---|---|---|---|---|
[41] | GC | Surgical resections and endoscopic biopsies | 15 | 14/15 (93.3%) | H&E, immunohistochemistry, immunofluorescence, whole-exome sequencing, next-generation sequencing, therapy response evaluation |
[40] | GC | Malignant ascites | 12 | 11/12 (91.7%) | H&E, immunohistochemistry, whole-exome sequencing, therapy response evaluation |
[46] | GC | NA | 63 | > 90% | H&E, immunohistochemistry, whole-exome sequencing and transcriptome analysis, therapy response evaluation |
[53] | GEP-NEN | Fresh clinical samples | 16 GEP-NET and 22 NEC lines | NA | H&E, immunohistochemistry, whole-exome sequencing and transcriptome analysis |
[i]GC: gastric cancer; GEJ: gastroesophageal junction; H&E: haematoxylin-eosin staining; NA: not available; GEP-NEN: gastroenteropancreatic neuroendocrine neoplasm; NEC: neuroendocrine carcinoma